tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JBM (Healthcare) to Review Interim Results and Dividend

JBM (Healthcare) to Review Interim Results and Dividend

JBM (Healthcare) Ltd. (HK:2161) has released an update.

Elevate Your Investing Strategy:

JBM (Healthcare) Limited has scheduled a board meeting on November 19, 2024, to review and approve its interim financial results for the six months ending September 30, 2024. The meeting will also consider the recommendation of an interim dividend and address other business matters. This meeting could provide vital insights into the company’s financial health and potential shareholder returns.

For further insights into HK:2161 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1